Papers
13
Total Citations
292
H-Index
8
About
Aaron A. Laviana is a urologic surgeon and health systems researcher whose work sits at the intersection of minimally invasive oncologic surgery and healthcare value analysis. His most influential contribution — a 2015 study on time-driven activity-based costing (TDABC) for localized prostate cancer treatment, now cited over 144 times — helped establish a rigorous framework for understanding the true costs of competing cancer therapies, a methodology he has since applied broadly across urologic procedures. Laviana has been a leading voice in evaluating robotic-assisted surgery, including comparative analyses of robotic versus open radical prostatectomy and cystectomy, robotic partial nephrectomy approaches, and novel techniques such as bladder neck intussusception. His 2023 research on same-day discharge robotic prostatectomy — emerging from adaptations driven by the COVID-19 pandemic — demonstrates his commitment to optimizing patient care pathways without compromising outcomes or satisfaction. Beyond surgical technique, Laviana has contributed meaningfully to patient-reported outcomes research, clarifying how validated instruments like the EPIC-26 translate into real functional expectations for prostate cancer patients. Collectively, his work advances both surgical innovation and the broader goal of delivering high-value, evidence-based urologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robot assisted radical prostatectomy: the new standard?14 citations · 2015
- 5
- 6
- 7
- 8
- 9
- 10